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Abstract
Many kinds of Chinese herb had been confirmed to have the character of anti-tumor, clinical
reports about anti-tumor effects of Chinese herb had also been found in recent years, but most of
the reports were focused on the clinical treatment of effectiveness for Chinese herb, on the other
hand, review about Chinese herbal related with molecules on cancer-cell-apoptosis was seldom,
many scientists could not believe such kinds of clinical describes about anti-tumor effects for
Chinese herb, because these describes were lack of molecular biology evidence. Kanglaite(KLT)
injection is an anti-tumor new drug which extracts from Chinese medicine-coix seed with modern
advanced pharmaceutical technology, it is also a new biphase extended-spectrum anticancer
medicine, the food and drug administration(FDA) of United States also approved a phase II trial of
KLT to test its efficacy in treating non-small-cell lung cancer. Some studies show it could inhibit
some anti-apoptotic gene and activate some pro-apoptotic gene, its injection solution is one of the
new anticancer medicine that can significantly inhibit a various kinds of tumor cells, so it has become
the core of research that how to further explore KLT injection to promote tumor cell apoptosis
by impacting on related genes. In this review, the relationship between KLT and some tumor cell
apoptosis molecules had been discussed and reviewed generally.
Review
In recent years, with the lucubrate on tumor cell biology
and molecular biology, it has been recognized that the
occurrence and development of tumor is not only the
result of cell proliferation disorders and disdifferentia-
tion, but also closely correlated with the abnormal apop-
tosis [1,2]. Although abnormal apoptosis can promote the
occurrence and development of tumor, we can also treat
tumor by promoting apoptosis of cancer cell [3,4]. Thus it
has become the new target in oncotherapy by way of
inducing apoptosis of cancer cell. Kanglaite(KLT) injec-
tionis a diphasic broad-spectrum anti-tumor new drug
which has depressant effect on many kinds of tumor cells,
it is extracted from the chinese crude drug-coixenolide
[5,6] and made use of the latest and most complex mod-
ern high technologies in process of preparation [7]. Ani-
mal experiments show that KLT mainly block G2+M
phase of cell circle, thereby reducing the mitotic division
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of cells, so the proliferation of tumor cell was inhibited, at
the same time it can also activate some pro-apoptotic fac-
tor, and further lead to apoptosis [8]. Clinical application
also shows that combined with chemotherapy, KLT has a
good effect on the treatment of advanced cancer, particu-
larly in digestive tract cancer, for example, the patient's life
span and quality of life improve significantly. The finding
show that this preparation has significantly depressant
effect and preonunced curative effect on a variety of cancer
cells [9]. Although the therapeutic measure of liver cancer
contain surgery, radiotherapy, chemotherapy, interven-
tional therapy and so on, their effect is not satisfactory so
far [10,11]. However, with the development of cell biol-
ogy, the theory of apoptosis presents a new hope and path
for the treatment of liver cancer, The present study has
found that KLT plays an important role in promoting
apoptosis of hepatoma cells [12]. It has been known that
the apoptosis of hepatoma cells is triggered by a variety of
receptor-mediated cell signaling, and a variety of protease
take part in the apoptotic signal transduction. In addition
many kinds of genes are also involved with apoptotic reg-
ulation of hepatoma cells. In this paper, the relationship
between KLT and the hepatoma cell apoptosis molecules
is going to be discussed and reviewed generally.
The influence of KLT on p53
There are two types of p53 genes: the wild type p53 gene
and the mutant p53 gene. The wild type p53 gene, which
is also known as the guardian of gene, is indispensable to
regulate the normal cells circle [13,14]. On the one hand,
as the important regulating factor in the process of apop-
tosis, the wild type p53 monitor the integrity of genes all
the time, on the other hand, as the nuclear transcripton, it
can respectively combines with DNA and RNA polymer-
ase to regulate expression of gene, it can also inhibit the
synthesis of DNA, take part in the repair of DNA, induce
cell growth stop at the phase of G0. In addition, the wild
type p53 gene can induce the Fas-mediated cell proce-
dural death after the damage of DNA, so that the regular
growth of cell is maintained. Wang JJ [8] had found, while
discussing the anticancer mechanism of KLT injection,
that the labeling index of wild type p53 in treat group
which received KLT injection is 16.8%, while the control
group had no expression at all. Furthermore, in the exper-
iment about KLT-induced apoptosis, Bao Y [15] discov-
ered that compared with the control group, the mRNA
level of the wild type p53 gene significantly Increased in
20 μl/ml KLT experimental group after 48 hours. And in
the experiment about apoptosis of multidrug resistance
phenotypic human breast cancer cell line MCF7adr and its
cell cycle arrest that induced by KLT. According to the
immunohistochemical detection, Guo JW [16] found that
the wild type p53 gene of MCF7adr in the control group is
negative, but the wild type p53 gene of MCF7adr in the KLT
experimental group is midrange positive, it can be
assumed that KLT could up-regulate the expression of p53
and extend half life of p53 protein. In addition, Wei CY
[12] observed 34 cases' hepatoma carcinoma cell that cul-
tivated in vitro and their changes after treated with KLT,
the results indicated that, compared with the control
group, the apoptosis of hepatoma carcinoma cell in KLT
experimental group is very significant, there was signifi-
cant difference between them, at the same time, the labe-
ling index of wild type p53 in the treat group is (8.39 ±
1.42)%, but the labeling index of wild type p53 in the
control group (2.11 ± 0.97)%, there was significant differ-
ence between these two groups. the phenomenon
recorded here is the same as the studies of Wang JJ, Guo
JW and Bao Y which had indicated [8,15,16]. In conclu-
sion, KLT injection's may induce the apoptosis of tumor
cell by way of up-regulate the expression of p53 genes.
The effect of KLT on the bcl-2 genes
Proto-oncogenes bcl-2 is the most definite apoptotic
antagonist gene so far. In 1984, It was first cloned in t(14;
18) (q32; q21) chromosome translocation of follicular
lymphoma cell line. But many studies had also confirmed
that the high expression of this gene might inhibit the
apoptosis of a variety of cells as well[17,18], thereby it can
participate in the occurrence of a variety of tumor. When
studying the anticancer mechanism of KLT, Wang JJ [8]
found that the labeling index of bcl-2 gene was (16.80 ±
3.77)% in the control group, which is higher than that
(6.6%) in the 10 μl/ml KLT treat group. Moreover, accom-
panied with the concentration of KLT increase, the gene
expression of bcl-2 decreased in KLT group. In the experi-
ment about KLT-induced the apoptosis of pancreatic can-
cer cells, according to the Western blot analysis, Bao Y [15]
discovered that the expression of bcl-2 protein decreased
after 72 hours when application of KLT at 20 μl/ml, the
results of these two experiments above-mentioned may
indicate that KLT induced the apoptosis of cells by down-
regulating the expression of bcl-2 genes. Nevertheless,
when studying the KLT- induced the apoptosis of cancer
cell(HL60), Li Y [19] make use of RT-PCR to detect the the
gene expression of bcl-2, there was no significant change
in genetic transcription after 24 hours when using KLT at
10 ul/ml. So, whether KLT induces apoptosis of cancer cell
by down-regulating the expression of bcl-2 genes isn't yet
clear, and its role in hepatoma is not learned, which
requires further study and research.
The effect of KLT on Fas-genes
Fas gene is located on the No.10 chromosome q23, with
a length about 25 kb, the codogenic Fas protein consists
of 325 amino acids and it can be expressed in many tis-
sues. When Fas protein combining with Fas ligand, signal
of apoptosis is send to the cell and the apoptosis of cell is
induce [20,21] Many anticancer drugs can induce the
apoptosis of cancer cell by up-regulating the expression ofJournal of Experimental & Clinical Cancer Research 2008, 27:31 http://www.jeccr.com/content/27/1/31
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Fas gene [22]. when studying the KLT- induced the apop-
tosis of cancer cell(HL60), Li Y [19] make use of RT-PCR
to detect the the gene expression of Fas, she observed that
genetic transcription strengthened after 24 hours when
using KLT at 10 ul/ml. Han SX [23] proved that KLT injec-
tion can induce the apoptosis of human cervical carci-
noma cell by raising the level of Fas gene. Similarly, the
experiment, which detected the expression of Fas receptor
on the surface of osteogenic sarcoma cell under different
concentration of KLT [24], showed that under the KLT
concentration of 0 ul/ml, 1 ul/ml, 5 ul/ml, 10 ul/ml and
20 ul/ml, the amount of Fas mRNA detected by the RT-
PCR analisis is (0.12 ± 0.02) ul/ml, (0.27 ± 0.05) ul/ml,
(0.35 ± 0.09) ul/ml, (0.46 ± 0.14) ul/ml and (0.51 ± 0.16)
ul/ml respectively, so they considered that accompanied
with the concentration of KLT increase, the level of Fas
gene in the cancer cell significantly increased. Anyway,
KLT may induce apoptosis of cancer cell by up-regulating
the expression of Fas genes, but its effect on the Fas gene
of liver cancer cell should be further studied.
The effect of KLT on caspase-3
Caspases is a group of prolease that induce the apoptosis
of cell. Under the normal circumstances, the strict sub-
strate specificity and high effectivity of the activated cas-
pases can assures its narrow spectrum of proteolysis
during the process of apoptosis [25,26]. The caspases
selectively Shear a group of protein in a simpatico way
that lead to functional failure or structural changes of the
protein. If the activity of caspases is suppressed, the cellu-
lar apoptosis could be disturbed, which could lead to the
occurrence and development of tumor, because the
dynamic balance between cellular apoptosis and prolifer-
ation is disturbed. Caspases-3 and Caspases-8 are the
most widely studied in caspases family. Caspase-3, as a
important member in the caspases family, is a major func-
tional enzyme in the pathway of cellular apoptotic sig-
nal[27,28]. Caspases-3 can cause the clearage of its
substrate PARP(116 × 103) and transferred into opyeptide
24 × 103 and 89 × 103 and thereby activate the endonu-
clease to trigger the complete degradation of DNA. Many
factors that regulate the cellular apoptosis can react
through caspase-3 prolease. The depressor of caspase-3
can restrain the activation of caspase-3 and degrade the
activity of it, so that the apoptosis of cancer cell is
restrained [29,30]. Bcl-2 and p53 both interact with cas-
pase family [31-33]. Some report have discovered, while
studying KLT-induced the apoptosis of human pancreatic
cancer Paru-8988 cell, that the increase of caspase-3 total
protein also show obviously time dependence [34]. More-
over, through the test on the substrate of caspase-3-PARP,
no degradation product (89 × 103) strap was found in the
control group, but the degradation product (89 × 103)
strap was discovered after 6 hours in KLT group, which
indicates that caspase-3 have enzyme activity. However,
no study or research about the effect of KLT on the liver
cancer cell had done.
The effect of KLT on other related genes
PCNA (proliferating cell nuclear antigen) is a subunit of
DNA polymerase and cell cycle-dependent protein whose
maximum appearance in the S phase. Some research
shows that the expression of PCNA is connection with the
low grade tissues[35,36]. Wang JJ found that the gene
expression of nuclear PCNA increased obviously, and the
labeling index of PCNA was 15. 2% after 48 hours when
0.2 mg/ml KLT effected on the renal cancer cells, while
hardly any gene expression of nuclear PCNA was observed
in the control group [8]. They believed that PCNA took
part in the reparative process of KLT- induced DNA injury,
and when the degree of DNA injury is too serious to be
repaired by PCNA, other genes such as P53 and Bcl-2 will
send signals to trigger the apoptosis of cell and they were
also convinced that the anticancer effect of KLT was a
result of multiple gene interaction and restriction
[8,15,16,19].
c-myc is one of the core protein – myc family in oncogene,
and it not only is a positive controlling gene in cellular
growth and cell life circle, but also take part in the progress
of apoptosis, that is to say, it has dualism[37]. Under a cir-
cumstances of growth inhibiting, improper expression of
c-myc could induce regulatory failure of normal cell life
circle and apoptosis[38]. when studying the KLT- induced
the apoptosis of cancer cell(HL60), Li Y make use of RT-
PCR to detect the the gene expression of c-myc, she
observed that there was no significant change in genetic
transcription after 24 hours when using KLT at 10 ul/ml
[19]. As bcl-2 gene, we should do further research and
study on it.
P21WAFI/CIPI is the downstream gene of p53 gene, its acti-
vation contain the p53 dependent path and the p53 non-
dependent path[39]. The protein product of P21WAFI/CIPI
can combine with cell circle protein, cyclin-dependent
kinase(CDK), and proliferating cell nuclear anti-
gen(PCNA) to form a quaternionic complex that can stop
the cell life circle and depress the cell growth. Guo JW dis-
covered that while up-regulate the expression of p53 pro-
tein, KLT can raise the expression of p21WAFI/CIPImRNA
and protein, it indicates that KLT can induce apoptosis of
cancer cell by way of the p53 dependent path to up-regu-
late the expression of p21WAFI/CIPI [16].
Furthermore, some researchers found that KLT can up-reg-
ulate the level of ubiquitin C, RAD17 genes and down reg-
ulate t the level of cyclin A, cyclin E1, cyclin F gene in
studying the influence of KLT on Patu-8988 cell life circle
and gene expression [40].Journal of Experimental & Clinical Cancer Research 2008, 27:31 http://www.jeccr.com/content/27/1/31
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In addition, some study [41] show that the genes regu-
lated apoptosis are not isolated, they can influence and
restrict with each other, for example, Bcl-2 family, IAPs
family, c-myc, P53, P35, can affect activation of caspase-3
through regulating activation of caspase-8 and caspase-
9[42]. so Kanglaite may promote the interaction of those
genes to form a network cycle, amplify cascade reaction
and further promote apoptosis. but there is no related
research at the present stage.
Conclusion
Now, the study of KLT-induced apoptosis is focused on
the above-mentioned gene. In short, KLT induce apopto-
sis of cancer cell by way of up regulating the expression of
p53 gene, Fas gene, Caspase-3, PCNA, p21WAFI/CIPI and
down regulating the expression of cyclin A, cyclin E1, cyc-
lin F gene. But its effect on the expression of bcl-2 gene
and c-myc gene is not yet clear.
The occurrence of malignant tumor may be caused by the
abnormal proliferation of cell or the inhibition of cellular
apoptosis pathway. The proliferation of tumor cell and
the apoptosis of tumor cell are not only affected by many
factors and pathways such as drugs, radioactive ray, etc,
but also regulated by some tumor genes or tumor-sup-
pressing gene. It has been proved that the Chinese crude
drug-induced apoptosis is one important anticancer
mechanism of Chinese crude drug, and it is also relevant
to the concentration of the medicine[43]. Just as the result
of experimental treatment on hepatoma of mice that we
have done [44], we found that KLT can made the cancer
cells stop in the G2+M phase of cell life circle, and prevent
them form entering the G0 and G1 phase. so it can induce
the apoptosis and suppress growth of cells without any
effect on the surrounding normal tissues or causing
Inflammatory reaction which are unique characteristics.
based on these characteristics, KLT has been used in the
treatment on many kinds of malignant tumor, and the
clinical effect show that KLT can not only repress tumor
directly, improve the quality of life obviously, enhance
the patient's immunity, but also enhance the effectiveness
of chemotherapy and reduce side effects [45-47], which is
consistent with its pharmacology above-mentioned How-
ever, the relationship between the apoptosis of hepatoma
carcinoma cell and gene is further studied, although these
research can not fully reveal the mechanism of KLT-
induced apoptosis, and its experimental result is still pre-
liminary, the trend of using KLT to prevent and cure liver
cancer is already formed, and with the development of
modern medical technologies, its mechanism will
undoubtedly be revealed in the near future. and KLT will
bring new hope for the treatment of cancer and the pro-
tection of normal tissues with the more sufficient evi-
dence of its effect on liver cancer and other tumor in
clinical trials.
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